Phreesia Inc
$ 8.60
0.47%
14 Apr - close price
- Market Cap 522,562,000 USD
- Current Price $ 8.60
- High / Low $ 8.84 / 8.53
- Stock P/E 215.00
- Book Value 5.56
- EPS 0.04
- Next Earning Report 2026-05-27
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA N/A %
- ROE 0.01 %
- 52 Week High 32.76
- 52 Week Low 7.77
About
Phreesia, Inc. provides integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company is headquartered in Raleigh, North Carolina.
Analyst Target Price
$16.44
Quarterly Earnings
| Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 | Jul 2023 | Apr 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-01 | 2025-12-08 | 2025-09-05 | 2025-05-28 | 2025-03-12 | 2024-12-09 | 2024-09-04 | 2024-05-30 | 2024-03-14 | 2023-12-05 | 2023-09-06 | 2023-05-31 |
| Reported EPS | 0.4404 | 0.07 | 0.01 | 0.2259 | 0.1848 | 0.0367 | -0.31 | -0.35 | -0.21 | -0.25 | -0.34 | -0.38 |
| Estimated EPS | 0.0614 | -0.0014 | -0.06 | -0.42 | 0.1106 | -0.27 | -0.36 | -0.48 | -0.26 | -0.36 | -0.42 | -0.46 |
| Surprise | 0.379 | 0.0714 | 0.07 | 0.6459 | 0.0742 | 0.3067 | 0.05 | 0.13 | 0.05 | 0.11 | 0.08 | 0.08 |
| Surprise Percentage | 617.2638% | 5100% | 116.6667% | 153.7857% | 67.0886% | 113.5926% | 13.8889% | 27.0833% | 19.2308% | 30.5556% | 19.0476% | 17.3913% |
Next Quarterly Earnings
| Apr 2026 | |
|---|---|
| Reported Date | 2026-05-27 |
| Fiscal Date Ending | 2026-04-30 |
| Estimated EPS | 0.06 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: PHR
2026-04-14 21:10:06
Pomerantz LLP has initiated an investigation into Phreesia, Inc. (NYSE: PHR) on behalf of investors, probing potential securities fraud or unlawful business practices. This comes after Phreesia announced reduced revenue guidance for fiscal year 2026, attributing it to weaknesses in pharmaceutical marketing and its Networking Solutions segment. Following this news, Phreesia's stock price dropped significantly.
2026-04-14 20:10:06
Phreesia, a leader in patient intake, outreach, and activation, has been recognized by Becker’s Hospital Review in its 2026 list of “Revenue Cycle Management Companies to Know.” This acknowledgment highlights Phreesia's role in helping healthcare organizations manage revenue cycle operations through innovative solutions that digitize intake, streamline payment workflows, and improve collections. The company's platform aims to accelerate cash flow, simplify administrative tasks, and enhance operational efficiency for healthcare providers.
2026-04-14 14:41:44
Phreesia (PHR) stock experienced a 5.1% increase, outperforming its sector. The article prompts an evaluation of whether this upward trend is sustainable given its recent performance and potential market factors.
2026-04-14 03:39:34
David Linetsky, President, Network Solutions at Phreesia, Inc., sold 8,332 shares of common stock for $67,239 on April 10, 2026, while the stock trades near its 52-week low. He also disposed of additional shares to cover tax obligations. This comes alongside mixed analyst reactions to Phreesia's better-than-expected Q4 fiscal 2026 revenue but lowered fiscal 2027 guidance due to reduced pharmaceutical advertising spend.
2026-04-14 00:39:34
Allison C. Hoffman, General Counsel & Secretary at Phreesia, Inc., sold shares worth $116,877 and $138,723 on April 10 and April 9, 2026, respectively. These transactions were to cover tax obligations from restricted stock units and not personal sales. The company recently reported better-than-expected Q4 fiscal 2026 revenues and adjusted EBITDA, but lowered its fiscal 2027 revenue outlook due to reduced pharmaceutical client ad spending.
2026-04-14 00:39:34
Allison C. Hoffman, General Counsel & Secretary of Phreesia (NYSE: PHR), reported an open-market sale of 14,483 shares at $8.07 per share, executed under a Rule 10b5-1 trading plan adopted on December 19, 2025. Additionally, 15,161 shares were withheld by Phreesia at $9.15 per share to cover tax obligations related to restricted stock unit settlement, which was not a personal sale. Following these transactions, Hoffman holds 163,485 shares of Phreesia.
